ANALYST RECOMMANDATIONS : AstraZeneca, General Electric, Parker-Hannifin, PayPal, Qiagen...
Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.
- AstraZeneca: Barclays still consider the stock as a Buy opportunity. The target price has been revised upwards and is now set at GBp 11000, compared with GBp 10000 previously.
- AudioBoom Group: Finncap initiated coverage with a recommendation of corporate. PT rises 47% to 1,600 pence.
- Babcock: Barclays cut the recommendation to equal-weight from overweight. PT up 9% to 352 pence=
- ConocoPhillips: Societe Generale cut the recommendation on ConocoPhillips to hold from buy. PT up 1.7% to $77
- Five9: JPMorgan adjusts price target to $160 from $213, maintains neutral rating
- General Electric: Deutsche Bank raised the recommendation to buy from hold. PT up 18% to $131
- International Consolidated Airlines Group: Goldman Sachs is keeping its Neutral rating. The target price is revised upwards from GBp 190 to GBp 180.
- Johnson Service: HSBC upgrades to buy from hold. PT up 31% to 170 pence
- Parker-Hannifin: BMO Capital adjusts price target to $400 from $375, keeps outperform rating
- PayPal: Atlantic Securities adjusts pt to $280 from $315, maintains overweight rating
- Qiagen: Deutsche Bank still considers the stock as a Buy opportunity.
- Standard Chartered: Jefferies remains Buy with a target price raised from GBp 736 to GBp 794.
- Tencent Music Entertainment Group: Citigroup downgrades to neutral from buy, adjusts pt to $8.50 from $9
By 
